secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2026-02-18T23:59:59+00:00
Accession:  0000896264-26-000014
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q4 net loss $1.8M; core customers down 15%; FY2026 guidance flat to 8% growth
--------------------------------------------------------------------------------

- Q4 net loss $1.8M vs profit $4.5M YoY; adjusted diluted EPS $0.60 (down 6% from $0.64).
- FY2025 net sales $925M (+8% YoY); core nutritional net sales down 8%, active customers down 15% to 387k.
- Recorded $7M goodwill impairment and $6.5M cost realignment charge in Q4, boosting effective tax rate to 72.4%.
- FY2026 guidance: consolidated net sales $925M-$1.0B (flat to 8% growth); adjusted diluted EPS $1.95-$2.29.
- Hiya net sales grew 17% in FY2025; Rise Wellness net sales tripled; non-core now 16% of consolidated sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626426000014/0000896264-26-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626426000014/usna-20260217.htm
  HTML page:      https://secwatch.observer/filing/0000896264-26-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer